Intangible Assets

9 Months Ended

Mar. 31, 2015

3.	Intangible Assets

Intangible assets consist of the following based on our preliminary determination of the fair value of identifiable assets acquired (see footnote 2):

	March 31, 2015
	Weighted Average Amortization Period (in Years)		Gross Carrying Amount		Accumulated Amortization		Net
Trade names		7	$	31	$	5	$	26
Licenses		7		498		80		418
Customer relationships		3		458		172		286
Device registration		7		93		10		83
Covenants not to compete		5		955		216		739
Clinical protocols				19,870		--		19,870
Total		5.1	$	21,905	$	483	$	21,422

The change in the gross carrying amount is due to foreign currency exchange fluctuations and a $117 impairment of the device registration and licenses intangible assets due to discontinuing a cord-blood product. Amortization of intangible assets was $114 and $343 for the three months and nine months ended March 31, 2015. Clinical protocols have not yet been introduced to the market place and are therefore not yet subject to amortization. Our estimated future amortization expense for years ended June 30, is as follows:

Year Ended June 30,
April 1 – June 30, 2015	$	115
2016		452
2017		370
2018		275
2019		203
Thereafter		137
Total	$	1,552